76
Participants
Start Date
April 1, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Chronocort
Hydrocortisone modified-release capsule 5 mg and 10 mg
Diurnal Investigational Site in Caen, Caen
Diurnal Investigational Site in Toulouse (Children's hospital), Toulouse
Diurnal Investigational Site in Toulouse, Toulouse
Diurnal Investigational Site in Florida, Jacksonville
Diurnal Investigational Site in Pessac, Pessac
Diurnal Investigational Site in Michigan, Ann Arbor
Diurnal Investigational Site in Iowa, Iowa City
Diurnal Investigational Site in Wisconsin, Milwaukee
Diurnal Investigational Site in Minnesota, Rochester
Diurnal investigational Site in Lyon, Lyon
Diurnal Investigational Site in Texas, Dallas
Diurnal Investigational Site in Paris, Paris
Diurnal Investigational Site in Nevada, Las Vegas
Diurnal Investigational Site in California, Los Angeles
Diurnal Investigational Site in California, Orange
Diurnal Investigational Site in Washington, Seattle
National Institutes of Health Center, Bethesda
Diurnal Investigational Site in Asahi-ku, Yokohama
Diurnal Investigational Site in Yushima, Bunkyō-Ku
Diurnal Investigational Site in Okura, Setagaya-Ku
Diurnal Investigational Site in Toyama, Shinjuku-Ku
Neurocrine UK Limited
INDUSTRY